Cooper Companies, Inc. (The) (NYSE:COO) PT Set at $273.00 by Robert W. Baird

Cooper Companies, Inc. (The) (NYSE:COO) has been given a $273.00 target price by analysts at Robert W. Baird in a report issued on Monday, October 16th. The firm currently has a “buy” rating on the medical device company’s stock. Robert W. Baird’s price objective suggests a potential upside of 11.69% from the stock’s previous close.

Several other equities research analysts have also recently commented on the stock. BMO Capital Markets reiterated a “buy” rating and issued a $272.00 price target on shares of Cooper Companies, Inc. (The) in a research report on Friday, October 13th. Zacks Investment Research upgraded shares of Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $265.00 price target on the stock in a research report on Tuesday, October 10th. Jefferies Group LLC reissued a “buy” rating and issued a $250.00 price target on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Stephens reissued an “equal weight” rating and issued a $250.00 price target (up previously from $235.00) on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Finally, Oppenheimer Holdings, Inc. reaffirmed a “hold” rating and set a $250.00 target price on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Six equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $261.11.

Shares of Cooper Companies, Inc. (NYSE:COO) opened at 244.43 on Monday. Cooper Companies, Inc. has a 12 month low of $158.73 and a 12 month high of $256.39. The firm has a market cap of $11.96 billion, a price-to-earnings ratio of 35.05 and a beta of 0.54. The stock has a 50 day moving average of $239.84 and a 200 day moving average of $232.96.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its quarterly earnings data on Thursday, August 31st. The medical device company reported $2.64 earnings per share for the quarter, beating analysts’ consensus estimates of $2.58 by $0.06. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.00%. The business had revenue of $556.00 million for the quarter, compared to analysts’ expectations of $552.32 million. During the same period in the previous year, the business earned $2.30 earnings per share. The company’s revenue was up 8.0% on a year-over-year basis. On average, equities research analysts expect that Cooper Companies, Inc. will post $9.73 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Cooper Companies, Inc. (The) (NYSE:COO) PT Set at $273.00 by Robert W. Baird” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2017/10/28/robert-w-baird-reiterates-273-00-price-target-for-cooper-companies-inc-the-coo.html.

In other news, Director Gary S. Petersmeyer sold 3,977 shares of the company’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.60% of the stock is owned by insiders.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Advisory Services Network LLC raised its stake in shares of Cooper Companies, Inc. (The) by 30.6% in the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock valued at $109,000 after purchasing an additional 107 shares in the last quarter. YorkBridge Wealth Partners LLC raised its stake in shares of Cooper Companies, Inc. (The) by 2.1% in the second quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock valued at $126,000 after purchasing an additional 11 shares in the last quarter. Archford Capital Strategies LLC grew its position in Cooper Companies, Inc. (The) by 116.7% in the first quarter. Archford Capital Strategies LLC now owns 674 shares of the medical device company’s stock valued at $135,000 after acquiring an additional 363 shares during the period. Acrospire Investment Management LLC grew its position in Cooper Companies, Inc. (The) by 50.0% in the second quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock valued at $144,000 after acquiring an additional 200 shares during the period. Finally, Visionary Asset Management Inc. bought a new stake in Cooper Companies, Inc. (The) in the second quarter valued at $201,000. Institutional investors and hedge funds own 96.04% of the company’s stock.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Analyst Recommendations for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply